Insulin Therapy and Outcomes of Revascularization Procedures for Chronic Limb Threatening Ischemia in the Best-CLI Trial
Alameddine D, Hamouda M, Doros G, Conte M, Rosenfield K, Strong M, Menard M, Farber A, Hamdan A, Malas M, Ochoa Chaar C. Insulin Therapy and Outcomes of Revascularization Procedures for Chronic Limb Threatening Ischemia in the Best-CLI Trial. Journal Of Vascular Surgery 2025 PMID: 40886741, DOI: 10.1016/j.jvs.2025.08.033.Peer-Reviewed Original ResearchChronic limb-threatening ischemiaAdverse limb eventsLimb-threatening ischemiaLower extremity revascularizationOutcomes of patientsDiabetes mellitusBEST-CLIHbA1c levelsInsulin therapyInsulin-requiring DMOpen revascularizationInsulin requirementsLow riskLimb eventsExtremity revascularizationGlucose controlHbA1c <7BEST-CLI trialMinor amputationMajor amputationCox regression modelsOutcomes of revascularization proceduresBaseline HbA1c levelsWound gradeObservational study
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply